Philip Prince

About Philip Prince

Portfolio Leader with 20+ years of experience advancing programs from discovery and development through commercialization across both small and large organizations. Proven track record of developing, differentiating and launching multiple brands and indications within rare disease and hematology/oncology. Entrepreneurial leader with collaborative mindset focused on building high-performance organizations by translating scientific innovation into business value.

Experience

1. Vice President, Portfolio Lead

   Agios Pharmaceuticals

   Sep 2024 — Present · Cambridge, MA, US

   Champion portfolio strategy and lead strategic oversight for all Programs from pre-clinicalthrough commercialization- Collaborate with executive leadership team to prioritize portfolio/program investmentdecisions, providing clear analysis on revenue, expense and risk trade-offs to align withenterprise strategy and drive value creation- Spearheaded the management of multiple high-stakes enterprise risks, collaborating withcross-functional teams to successfully design and implement effective mitigation plans- Identified gaps in existing research strategy and contributed to the development of a newstrategy along with a new organizational model for its maintenance and execution.

Education

• University of Michigan - Stephen M. Ross School of Business

  Master of Business Administration (MBA), Marketing

• Missouri University of Science and Technology

  Bachelor of Science (BS), Chemical Engineering

Skills

• Competitive Analysis
• Supply Chain
• Cross-Functional Team Leadership
• Competitive Intelligence
• Marketing Strategy
• Market Research
• Pharmaceutical Industry
• Oncology
• Statistics
• Project Management
• Pharmaceutical Sales
• Marketing Management
• Market Analysis
• Hematology
• Data Analysis
• Six Sigma
• Segmentation